TAVI registries and durability

Session comprising selected EuroPCR 2017 late-breaking trial submissions

Chairpersons: A. Cribier, R. Makkar

Presentations available when logged in:

  • One-year results from the Women in TAVI (WIN-TAVI) registry
  • SOURCE 3 post approval registry - one-year outcomes in 1945 TAVI patients with a 3rd generation balloon expandable transcatheter heart valve
  • Real-world experience using a 2nd generation self-expanding prosthesis: 1-year outcomes of 1000 patients enrolled in the SAVI-TF registry
  • The RESPOND study at one-year: primary endpoint outcomes with a repositionable and fully retrievable aortic valve in routine clinical practice
  • Real-world use of a repositionable self-expanding transcatheter aortic valve: primary results of the FORWARD study
  • Final five-year clinical and echocardiographic results of treatment for severe aortic stenosis with a self-expanding bioprosthesis
  • Prosthesis-related events and echocardiographic data throughout 9-years follow-up after TAVI
  • Longevity of transcatheter and surgical bioprosthetic aortic valves in patients with severe aortic stenosis and lower surgical risk